NAD+ is a coenzyme involved in normal cellular metabolism. That role has generated interest in supplements, nasal sprays, injections, and IV infusions. But an important molecule in the body is not automatically a treatment everyone needs. If you are considering NAD+ therapy at Luxura Med Spa, start with a clear discussion of your goal and the available evidence.
What Does NAD+ Research Show?
A 2019 pilot study of intravenous NAD+ examined changes in blood and urine metabolites during an infusion. That helps researchers understand how the body handles NAD+, but it does not establish that treatment reverses aging, reliably boosts energy, or treats depression, anxiety, or PTSD.
A 2026 retrospective pilot study comparing IV NAD+ and nicotinamide riboside evaluated short-term tolerability in a commercial setting. Its limited design and follow-up do not establish long-term wellness benefits. Reported symptoms during NAD+ infusions included gastrointestinal discomfort, increased heart rate, and chest pressure.
Ask whether a claim is based on human clinical outcomes or only a laboratory finding. NAD+, nicotinamide riboside, and other related compounds are not interchangeable, and evidence for one should not be assumed to prove another works.
Nasal Spray, Injections, and IV: Different Questions
Luxura has discussed several delivery options. Current availability and suitability should be confirmed during a consultation; the route alone does not establish that one option is more effective.
Nasal Spray
Ask what evidence supports the exact formulation and intended outcome. Convenience is different from proof of an immediate energy boost, and a nasal product should not inherit claims from an IV study.
Injections
Discuss the product source, prescription, storage, and follow-up arrangements. If home administration is proposed, obtain individualized training and instructions from the prescribing team. Do not improvise a dose or injection schedule.
IV Infusions
Our IV therapy page provides service context. Ask how the infusion will be monitored, what symptoms require stopping it, and who is available if a problem occurs. More time in an infusion chair does not establish a greater benefit.
Product Quality and Potential Risks
The FDA has warned about unsuitable ingredients used in compounded NAD+ injectables and reported reactions including severe chills, shaking, vomiting, and fatigue. The agency linked those reports to potential endotoxin contamination. Ask which pharmacy prepares the product and whether it is compounded; compounded drugs are not FDA-approved.
Deciding Whether to Proceed
Persistent fatigue, mood changes, or poor concentration deserve an appropriate medical assessment. NAD+ should not replace established treatment for a diagnosed condition. A consultation should leave you with clear answers about the proposed goal, uncertainty, costs, and reasons to stop.
- What specific problem are we trying to address?
- What evidence supports this formulation and route?
- What alternatives should I consider?
- How will we measure benefit and review side effects?
Contact Luxura Med Spa for a discussion of NAD+ options and realistic expectations.
